• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 08-Dec-2022 14:16 PM
SENSEX
62,536.43
125.75 (0.20%)
NIFTY
18,584.55
24.05 (0.13%)
    No Companies Visited

Back to news list
  • Dr. Reddy's and Senores Pharmaceuticals launch Ketorolac Tromethamine Tablets

    Used in management of moderately severe acute pain in adults

    Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. today announced the launch of Ketorolac Tromethamine Tablets USP, 10 mg, a therapeutic generic equivalent of the reference listed drug Toradol Tablets, 10 mg in the U.S. market approved by the U.S. Food and Drug Administration (USFDA).

    Ketorolac Tromethamine Tablets USP, 10 mg, is a nonsteroidal anti-inflammatory drug (“NSAID”) indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level and only as continuation treatment following intravenous or intramuscular dosing of ketorolac tromethamine, if necessary.

    The Toradol Tablets, 10 mg brand and generic had U.S. sales of approximately $16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA. Dr. Reddy's Ketorolac Tromethamine Tablets USP, 10 mg, are available in bottle count sizes of 100.



    Back to news list
Previous Stories :
More






Corporate News

Quick Links

Market Statistics

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
9769005430
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 08-Dec-2022
  •  ( 13:08) Kalyan Jewellers to expand retail footprint by over 30% in CY23  
  •  ( 12:34) Barometers turn range bound; Nifty hovers below 18,600; VIX down 1.91%  
  •  ( 12:09) Dredging Corporation bags reclamation dredging contract from NRL  
  •  ( 11:53) Talbros Automotive bags order worth Rs 60 crore  
  •  ( 11:13) Sun Pharma Gujarat plant gets import alert from USFDA  
  •  ( 11:09) Macrotech Developers launches QIP issue  
  •  ( 10:22) Dharmaj Crop Guard lists at Rs 266 v/s IPO price Rs 237  
  •  ( 10:12) Tvs Motor arm acquires entire stake in German co  
  •  ( 09:54) JSW Steel crude steel production jumps 16% YoY in November  
  •  ( 09:50) Eveready Inds appoints Bibek Agarwala as CFO  
  •  ( 09:39) HCL Tech tie-up with Intel and Mavenir to deliver 5G enterprise solutions  
  •  ( 09:30) Market breadth strong  
  •  ( 09:30) Barometers trade with minor cuts  
  •  ( 08:38) Most Asian stocks trading lower  
Show News
08 December 2022 14:13
3211.00
(-0.49 %)
937.40
(2.48 %)
6573.25
(-0.79 %)
1617.05
(0.63 %)
831.80
(-0.31 %)
4349.10
(-0.30 %)
2666.20
(0.25 %)
1100.00
(-0.49 %)
1621.45
(0.71 %)
2695.00
(-0.46 %)
925.75
(0.40 %)
1179.40
(1.27 %)
1609.75
(0.29 %)
338.55
(-0.44 %)
1900.00
(-0.58 %)
2160.00
(1.72 %)
1270.20
(0.30 %)
8667.35
(0.13 %)
19746.20
(-0.82 %)
170.70
(-0.64 %)
217.50
(-1.67 %)
2650.40
(0.02 %)
611.90
(0.81 %)
979.00
(-3.76 %)
112.05
(0.72 %)
3353.05
(-0.81 %)
1074.45
(-0.46 %)
2593.80
(-0.09 %)
7194.00
(0.41 %)
403.80
(-0.65 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.